New Hookworm Vaccine Could Have ‘Tremendous Impact’ On World’s Poorest
Huffington Post: A New Malnutrition Vaccine for the World’s Poor
Peter Hotez, founding dean of the National School of Tropical Medicine, and Remko van Leeuwen, director of acquisitions at the Amsterdam Institute of Global Health and Development (AIGHD) Foundation and coordinator of the HOOKVAC consortium
“…[A] report just released in the prestigious medical journal, Blood, reveals that anemia is now one of the most important causes of global illness, especially among women and children. … [A] neglected tropical disease (NTD) called hookworm is one of the leading causes of anemia. … The good news is that the Sabin Vaccine Institute’s Product Development Partnership (Sabin PDP) is developing the world’s first human hookworm vaccine, which could have a tremendous impact on the health, economic, and social landscape of countries with high burdens of this disease. … [This] human hookworm vaccine has been referred to as an ‘antipoverty vaccine’ because of its potential ability to improve child development, pregnancy outcome, and the health and productivity of agricultural workers. By conquering a leading cause of anemia in the developing world, the vaccine could become a truly important global health intervention…” (6/25).